Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion type Assertion NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_head.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion description "[In a xenograft mouse model of human PC, CDF treatment significantly inhibited tumor growth, which was associated with decreased NF-?B DNA binding activity, COX-2, and miR-21 expression, and increased PTEN and miR-200 expression in tumor remnants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion evidence source_evidence_literature NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion SIO_000772 21408027 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion wasDerivedFrom befree-20140225 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion wasGeneratedBy ECO_0000203 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.